Asclepius Life Sciences Co-Hosts Harvard University School of Medicine Conference on ‘Genes, Technology, and Incalculable Ethics – The Family Office of the Future’

Asclepius Life Sciences Co-Hosts Harvard University School of Medicine Conference on ‘Genes, Technology, and Incalculable Ethics – The Family Office of the Future’


April 5, 2017:  Asclepius Life Sciences Fund, L.P. was proud to be a co-host of the Harvard University School of Medicine conference on ‘Genes, Technology, and Incalculable Ethics – The Family Office of the Future’.

The conference explored “the intersection of the hugely accelerating genomics revolution and families of significant wealth”.  “Our ability to sequence genomes, essentially identifying all components of our DNA, combined with big data analysis and technologies that will allow us to edit DNA, portend profound implications for generational health and well-being”, said the conference organizers.

Michael J. Levas, Co-Founder, Senior Managing Principal and Chief Investment Officer noted his gratitude and admiration for Dr. Church’s vision, accomplishments and leadership.

“It’s all too easy to dismiss the future. People confuse what’s impossible today with what’s impossible tomorrow.”-George Church, PH.D.

Notable faculty include:

Professor of Genetics, Harvard Medical School;Professor of Health Sciences and Technology at Harvard University and the Massachusetts Institute of Technology.

Professor of Genetics, Harvard Medical School; Director, Consortium for Space Genetics, Harvard Medical School; Director and Co-Founder of the Personal Genetics Education Project.

Clinical Professor of Psychiatry and Behavioral Sciences, University of Washington; Family Office Consultant, London, U.K.

Professor of Genetics, Harvard Medical School; Chair, Department of Genetics, Harvard Medical School; Current research focus Evolutionary Biology.

| Accredited Investors

The information contained in this web site has been prepared solely for accredited investors. It is for informational purposes and is not an offer to sell or purchase or a solicitation of an offer to sell or purchase any interests or shares in any of the funds managed by Asclepius Investment Strategies, LLC Such offers are made only by way of a private offering memorandum delivered to qualified investors.

| Contact

ASCLEPIUS LIFE SCIENCES FUND, L.P.
641 Lexington Avenue, Suite 1337
New York, NY 10022
Phone: (212) 634-6440
Fax: (212) 634-6480